381P Treatment rechallenge after grade 1 trastuzumab-deruxtecan related interstitial lung disease: A real-world experience
| Autor: | Natsuhara, K.H., Vella, M., Behr, S.C., Quintal, L., Chien, J., Melisko, M.E., Majure, M., Buckle, G.C., Ko, A.H., Rugo, H.S. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S378-S378 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|